Altrinsic Global Advisors LLC Sangamo Therapeutics, Inc Transaction History

Altrinsic Global Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $1.13 Million - $1.69 Million	-216,500 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $1.85 Million - $3.64 Million	-200,000 Reduced 48.02%	216,500 $3.38 Million
Q1 2019 May 14, 2019	BUY	$7.72 - $12.81 $281,780 - $467,565	36,500 Added 9.61%	416,500 $3.97 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $665,700 - $1.16 Million	70,000 Added 22.58%	380,000 $4.36 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $652,500 - $952,500	50,000 Added 19.23%	310,000 $5.26 Million
Q2 2018 Aug 13, 2018	BUY	$13.9 - $19.8 $695,000 - $990,000	50,000 Added 23.81%	260,000 $3.69 Million
Q1 2018 May 14, 2018	SELL	$16.7 - $26.35 $2.34 Million - $3.69 Million	-140,000 Reduced 40.0%	210,000 $3.99 Million
Q4 2017 Feb 13, 2018	SELL	$11.6 - $17.35 $2.2 Million - $3.3 Million	-190,000 Reduced 35.19%	350,000 $5.74 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $4.54 Million - $8.1 Million	540,000	540,000 $8.1 Million

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.